Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » ISOPP

ISOPP

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 27/04/20 by Zübeyda Derya Cetin1

Psychometric assessment of the Turkish MASCC Antiemesis Tool (MAT) for evaluating chemotherapy-induced nausea and vomiting in female patients with breast cancer

View resources
Last reviewed: 27/04/20 by Sara Gacia

Rationalization nivolumab by strategies cost-analysis

View resources
Last reviewed: 27/04/20 by Jennifer Laskey

Real world experience of cabozantinib in patients with renal cell carcinoma and cost saving from a free of charge access scheme

View resources
Last reviewed: 27/04/20 by Felice Musicco

Real-world clinical outcomes in metastatic breast cancer patients treated with palbociclib

View resources
Last reviewed: 27/04/20 by Zubeir A. Nurgat

Real-world experience of a standalone robotic device for compounding of patient-specific antineoplastic preparations in an ambulatory care pharmacy

View resources
Last reviewed: 27/04/20 by Amritpal Atwal

Reducing intensity conditioning (RIC) protocol harmonisation in the UK

View resources
Last reviewed: 27/04/20 by Lenka Dolezalova

Removal of existing antineoplastic drug contamination from hospital surfaces – comparison of efficiency of different disinfectants

View resources
Last reviewed: 27/04/20 by Mark Pearce

Review of the first year of a Pharmacist led Breast cancer oral therapies clinic. A joint working project between The Christie NHS Trust and Novartis

View resources
Last reviewed: 27/04/20 by Karunrat Tewthanom

Risk factors influencing cardiotoxicity due to trastuzumab in breast cancer: a case-control study at King Chulalongkorn Memorial Hospital

View resources
Last reviewed: 27/04/20 by Louise J. McKee

Risk stratification of neutropenic sepsis: is the national early warning score (NEWS)) equivalent to multinational association for supportive care in cancer (MASCC) score?

View resources
Last reviewed: 27/04/20 by Chandra Maraj

Development of advanced clinical pharmacy technician roles and responsibilities at Oxford University Hospitals NHS Foundation Trust (OUHFT)

View resources
Last reviewed: 27/04/20 by Octavio Ballesta-López

Economic impact of a capping strategy of nivolumab and pembrolizumab versus fixed-dose

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 2 3 4 … 13 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.